Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.7076
-0.0186 (-2.56%)
Feb 2, 2026, 3:44 PM EST - Market open
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $2.57 million as of February 2, 2026. Its market cap has decreased by -72.49% in one year.
Market Cap
2.57M
Enterprise Value
1.35M
1-Year Change
-72.49%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $2.57M, a decrease of -100.00%. That is a compound annual growth rate of -71.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.64M | -21.07% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 3.35M |
| Clearmind Medicine | 3.25M |
| Lyra Therapeutics | 3.16M |
| Jaguar Health | 3.06M |
| Propanc Biopharma | 3.04M |
| HCW Biologics | 3.00M |
| Bone Biologics | 2.94M |
| Cardio Diagnostics Holdings | 2.76M |